Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Klinik für Psychiatrie und Psychotherapie

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Holthoewer, D.; Kirschbaum, K. M.; Frisch, J. et al.

Pharmacodynamic Effects of Aripiprazole and Ziprasidone with Respect to P-Glycoprotein Substrate Properties

PHARMACOPSYCHIATRY. Bd. 46. H. 5. 2013 S. 175-180


Franke, A; Lieb, K

Pharmakologisches "Cognitive Enhancement"

Hessisches Ärzteblatt. H. 2. 2013 S. 87-90


Dreimüller, N; Lieb, K; Tadic, A

Pharmakotherapie der therapieresistenten Depression

Freitag CM, Barocka A, Fehr C, Grube M, Hampel H (Hrsg). Depressive Störungen über die Lebensspanne. 1. Aufl. Stuttgart: Kohlhammer 2013


Hiemke, Christoph; Shams, Mohamed

Phenotyping and Genotyping of Drug Metabolism to Guide Pharmacotherapy in Psychiatry

CURRENT DRUG DELIVERY. Bd. 10. H. 1. 2013 S. 46-53



Haji, Elnaz Ostad; Mann, Klaus; Dragicevic, Aleksandra et al.

Potential Cost-effectiveness of Therapeutic Drug Monitoring for Depressed Patients Treated With Citalopram

THERAPEUTIC DRUG MONITORING. Bd. 35. H. 3. 2013 S. 396-401


Gahr, Maximilian; Freudenmann, Roland. W.; Hiemke, Christoph et al.

Pregabalin abuse and dependence in Germany: results from a database query

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. Bd. 69. H. 6. 2013 S. 1335-1342


Schwarze, C. E.; Mobascher, A.; Pallasch, B. et al.

Prenatal adversity: a risk factor in borderline personality disorder?

PSYCHOLOGICAL MEDICINE. Bd. 43. H. 6. 2013 S. 1279-1291


Geschke, Katharina; Fellgiebel, Andreas; Laux, Nina et al.

Quality of Life in Dementia: Impact of Cognition and Insight on Applicability of the SF-36

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. Bd. 21. H. 7. 2013 S. 646-654


Haji, Elnaz Ostad; Wagner, Stefanie; Fric, Mirijam et al.

Quetiapine and Norquetiapine Serum Concentrations and Clinical Effects in Depressed Patients Under Augmentation Therapy With Quetiapine

THERAPEUTIC DRUG MONITORING. Bd. 35. H. 4. 2013 S. 539-545